DocMorris
  • About us
    • Profile
    • Strategy
    • Business
      • Business fields
      • Markets & brands
    • Sustainability
    • History

    Commitment at all levels: Our sustainability ambition of a “Healthier life” guides our daily actions.

    Read more
  • Investor Relations
    • Investor hub
    • Newsroom
    • Financial publications
    • Investment highlights
    • Corporate governance
      • Governance principles
      • Board of Directors
      • Executive Board
      • General Meeting
    • Financial calendar
    • Share
      • Share information
      • Analysts & consensus
      • Shareholder structure
    • Bonds

    Always up to date in our investor hub – the one-stop destination for all Group IR topics.

    Learn more
  • News
    • Newsroom
    • News service
    • Press materials

    Masters of precision: How our PTAs guarantee a safe supply of medicines

    Read more
    Masters of precision: How our PTAs guarantee a safe supply of medicines
  • Careers
    • Jobs
    • Areas of work
    • Locations
    • Culture
    • Diversity & inclusion
    • Leadership

    Join the e-Health pioneers.

    Learn more
© 2023 Zur Rose Group AG
    EN
Read more
31 Oct 2023
News
Reiner Kern takes over Communications and Public Affairs at DocMorris
Read more
Read more
19 Oct 2023
Ad hoc news
DocMorris strengthens path to profitable growth in third quarter; slightly reduced revenue outlook
Read more
Read more
20 Sep 2023
News
DocMorris launches retail media offer with Criteo
Read more
Read more
29 Aug 2023
News
TeleClinic and DasLab Transforming Early Detection in Germany, Launch At-Home Colorectal Cancer Screening
Read more
Read more
17 Aug 2023
Ad hoc news
DocMorris: Solid basis for sustainable, profitable growth
Read more
Read more
06 Jul 2023
News
DocMorris AG: DocMorris demands fully digital non-discriminatory access to e-prescriptions
Read more
Read more
26 May 2023
Ad hoc news
DocMorris announces results of tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
Read more
Read more
12 May 2023
Ad hoc news
DocMorris (formerly Zur Rose Group) announces a tender offer for any-and-all of its CHF 200 million outstanding bonds due 2024
Read more
Read more
11 May 2023
News
New stock exchange ticker symbol for DocMorris: DOCM (formerly ROSE)
Read more
Read more
04 May 2023
News
Annual General Meeting 2023: Zur Rose Group AG to be renamed DocMorris AG (stock exchange ticker symbol DOCM)
Read more
Zur Rose Group AG

Follow us

DocMorris

Sustainability Investor hub Newsroom Jobs

Brands

DocMorris PromoFarma by DocMorris TeleClinic

Terms & services

Contact Legal notice Privacy policy Imprint
Privacy settings © 2023 DocMorris AG
      EN